Filing Flows › Comparisons › MNOV vs SLN
Medicinova vs Silence Therapeutics: MNOV and SLN compared
Medicinova is the larger company: $458K of revenue in its latest quarter (Q2 2026) against $422K for Silence Therapeutics (Q1 2026). Medicinova is growing faster (+241% against +197% a year earlier).
Where the money goes: MNOV and SLN
Medicinova (MNOV) · Q2 2026
Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Silence Therapeutics (SLN) · Q1 2026
Silence Therapeutics, Q1 2026: revenue $422K (+197% year over year), net loss $15.0M, operating cash flow −$15.6M. The chart follows the revenue to costs, profit and cash.
| Medicinova (MNOV) | Silence Therapeutics (SLN) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 2026 |
| Revenue | $458K | $422K |
| Revenue growth, Y/Y | +241% | +197% |
| Operating margin | -554.3% | n/m |
| Net earnings | −$2.3M | −$15.0M |
| Net margin | -504.8% | — |
| Operating cash flow | −$1.9M | −$15.6M |
Questions
Which is bigger, Medicinova or Silence Therapeutics?
Medicinova is the larger company: $458K of revenue in its latest quarter (Q2 2026) against $422K for Silence Therapeutics (Q1 2026).
Is Medicinova or Silence Therapeutics growing faster?
Medicinova is growing faster (+241% against +197% a year earlier).
More: Medicinova earnings · how Medicinova makes money · Silence Therapeutics earnings · how Silence Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed May 7, 2026). Fiscal quarters can end on different dates. Not investment advice.